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Abstract
Background. The 11th revision to the WHO International Classification of Diseases (ICD-11)
identified complex post-traumatic stress disorder (CPTSD) as a new condition. There is a
pressing need to identify effective CPTSD interventions.
Methods. We conducted a systematic review and meta-analysis of randomised controlled
trials (RCTs) of psychological interventions for post-traumatic stress disorder (PTSD),
where participants were likely to have clinically significant baseline levels of one or more
CPTSD symptom clusters (affect dysregulation, negative self-concept and/or disturbed rela-
tionships). We searched MEDLINE, PsycINFO, EMBASE and PILOTS databases (January
2018), and examined study and outcome quality.
Results. Fifty-one RCTs met inclusion criteria. Cognitive behavioural therapy (CBT), expos-
ure alone (EA) and eye movement desensitisation and reprocessing (EMDR) were superior to
usual care for PTSD symptoms, with effects ranging from g =−0.90 (CBT; k = 27, 95%
CI −1.11 to −0.68; moderate quality) to g =−1.26 (EMDR; k = 4, 95% CI −2.01 to −0.51;
low quality). CBT and EA each had moderate–large or large effects on negative self-concept,
but only one trial of EMDR provided useable data. CBT, EA and EMDR each had moderate or
moderate–large effects on disturbed relationships. Few RCTs reported affect dysregulation
data. The benefits of all interventions were smaller when compared with non-specific inter-
ventions (e.g. befriending). Multivariate meta-regression suggested childhood-onset trauma
was associated with a poorer outcome.
Conclusions. The development of effective interventions for CPTSD can build upon the suc-
cess of PTSD interventions. Further research should assess the benefits of flexibility in inter-
vention selection, sequencing and delivery, based on clinical need and patient preferences.
Introduction
The 11th revision to the World Health Organization’s International Classification of Diseases
(ICD-11) (WHO, 2018) includes two distinct sibling conditions, post-traumatic stress disorder
(PTSD) (code 6B40) and complex PTSD (CPTSD) (code 6B41), under a general parent category
of ‘Disorders specifically associated with stress’. PTSD is comprised of three symptom clusters
including (1) re-experiencing of the trauma in the here and now, (2) avoidance of traumatic
reminders and (3) a persistent sense of current threat that is manifested by exaggerated startle
and hypervigilance. ICD-11 CPTSD includes the three PTSD clusters and three additional clus-
ters that reflect ‘disturbances in self-organisation’ (DSO); (1) affect dysregulation, (2) negative
self-concept and (3) disturbances in relationships (Maercker et al., 2013). These disturbances
are proposed to be typically associated with sustained, repeated or multiple forms of traumatic
exposure (e.g. genocide campaigns, childhood sexual abuse, child soldiering, severe domestic
violence, torture or slavery) (Karatzias et al., 2017), reflecting loss of emotional, psychological
and social resources under conditions of prolonged adversity (Cloitre et al., 2013).
The qualitative distinction between PTSD and CPTSD symptomatology has been sup-
ported in different trauma samples (see Brewin et al., 2017) including those experiencing inter-
personal violence (Cloitre et al., 2013), rape, domestic violence, traumatic bereavement (Elklit
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et al., 2014), survivors of institutional abuse such as that occurring
within foster care and religious organisations (Knefel et al., 2015)
and refugees (Hyland et al., 2018). The distinction between PTSD
and CPTSD has also been confirmed in samples of young adults
(Perkonigg et al., 2016) and children (Sachser et al., 2016). The
second-order factorial structure of CPTSD in which the disorder
is comprised of both PTSD and DSO has also been supported in
previous research (e.g. Karatzias et al., 2016; Hyland et al., 2017a,
2017b; Shevlin et al., 2017).
To date a number of meta-analyses and systematic reviews have
investigated the effectiveness of PTSD treatments in general
(Callahan et al., 2004; Pelekis and Dahl, 2005; Bisson and
Andrews, 2007; Bisson et al., 2007; Taylor and Harvey, 2009,
2010; Barrera et al., 2013; Bisson et al., 2013; Sloan et al., 2013;
Watts et al., 2013; Ehring et al., 2014; Roberts et al., 2015).
Overall, previous meta-analyses have supported the efficacy of
trauma-focused psychological treatments, such as cognitive behav-
ioural therapy (CBT) and eye movement desensitisation and repro-
cessing (EMDR), for the treatment of DSM-IV PTSD, a condition
of three clusters of symptoms including re-experience, avoidance of
the traumatic reminders and hyperarousal. CBT and EMDR target
patients’ memories of their traumatic events and the personal
meanings of the trauma and typically include repeated in vivo
and/or imaginal exposure to the trauma, reappraisal of the mean-
ing of the trauma and its consequences, or some combination of
these techniques (e.g. Bisson et al., 2013). These approaches have
been identified as efficacious for a range of PTSD survivors, includ-
ing rape victims, survivors of childhood abuse, refugees, combat
veterans and victims of motor vehicle accidents (Foa et al., 2009),
although most existing evidence on these interventions concerns
single adult traumas (e.g. Bisson et al., 2013). There is disagreement
whether trauma-focused treatments are optimal for more complex
traumatic presentations such as CPTSD. For complex traumatic
presentations, a phase-based model, originally proposed by
Herman (1992), has been suggested as the preferred treatment
option (Cloitre et al., 2012).
Phased interventions address DSO and related problems in
day-to-day functioning (e.g. improving safety, emotion regulation
and social skills) first, while explicit exploration of the trauma
(e.g. exposure) is subsequently introduced (Cloitre et al., 2012b).
The rationale for this sequencing is twofold; firstly to increase emo-
tional, psychological and social resources to improve functioning
in daily life, and secondly, to use these resources to enhance the
effectiveness of trauma-focused work. Whilst there is some support
for this approach (e.g. Cloitre et al., 2010), it is uncertain if a sta-
bilisation phase is necessary and it might lead to unhelpful delays
in using more trauma-focused interventions (De Jongh et al.,
2016). Another approach to managing complex traumatisation
focuses on treating symptoms that are co-morbid with PTSD.
Empirical investigations have generally demonstrated the feasibil-
ity and effectiveness of these approaches. Examples include PTSD
with substance use disorder (SUD) (Mills et al., 2012) where SUD
and PTSD interventions are integrated and implemented relatively
simultaneously and PTSD with borderline personality disorder
(BPD) (Harned et al., 2014) where ideally the BPD and PTSD
interventions occur concurrently (but only once the patient has
developed the emotional and behavioural control to tolerate the
PTSD intervention). However, it is important to emphasise that
CPTSD is not identical to PTSD and its co-morbidity but is rather
a distinct disorder with a specific symptom profile.
Considering that ICD-11 CPTSD is a new condition, it will
take a substantial amount of time before an evidence base
accumulates regarding its treatment. However, there is evidence
on interventions that addressed at least partially the symptoms
of CPTSD, including those of DSO. The aim of this systematic
review and meta-analysis was to synthesise the evidence on effect-
iveness of treatments for the symptoms of CPTSD and identify
therapies that look most promising for treating the symptoms
of CPTSD. To achieve this goal, we examined evidence from trials
for PTSD where participants were also likely to have clinically sig-
nificant levels of one or more CPTSD DSO symptom clusters at
baseline, and where usable data on the effect of interventions
on these symptoms were reported. We also aimed to explore
the moderating effect of RCT quality, the developmental timing
of traumatic exposure (childhood v. adulthood), phased v. non-
phased interventions and individual v. group interventions on
treatment outcome. Our ultimate goal was to create a list of
research priorities to inspire future research in the treatment of
ICD-11 CPTSD.
Method
Protocol registration
A protocol for this systematic review and meta-analysis was pre-
registered (CRD42017055305) on February 2017. Changes to the
protocol are listed in the online Supplementary material.
Search strategy and study selection
The search process was conducted in three main phases. First,
MEDLINE, PsycINFO, EMBASE and PILOTS databases were
searched for studies published from database inception to
October 2017 using the following search terms: (‘PTSD’ or ‘post-
trauma*’ or ‘psychological stress*’ or ‘combat’ or ‘post-trauma*’ or
‘gross stress reaction’ or ‘stress disorder*’ or ‘trauma*’ or ‘psycho-
logical trauma’) AND (‘randomised’ or ‘randomized’ or ‘rando-
mised controlled trial’ or ‘randomized controlled trial’ or ‘RCT’)
AND (‘therapy’ or ‘psychological therapy’ or ‘psychological inter-
vention’ or ‘intervention’ or ‘treatment’). The only limiter applied
in this search was language (English only). Second, to update the
search, the same databases were searched for studies published
from database inception to January 2018 using similar search
terms: (‘PTSD’ or ‘posttrauma*’ or ‘psychological stress*’ or ‘com-
bat’ or ‘post-trauma*’ or ‘gross stress reaction’ or ‘stress disorder*’
or ‘trauma*’ or ‘psychological trauma’) AND (‘randomised’ or
‘randomized’ or ‘RCT’) AND (‘therapy’ or ‘intervention’ or ‘treat-
ment’). Limiters applied in this search were language (English
only), humans, age group (adolescence, defined as between 13
and 17 years old, and adulthood, defined as 18 years and
older), treatment and prevention, and randomised controlled
trials (RCTs). Third, the reference lists of earlier systematic
reviews and meta-analyses of clinical trials for PTSD were
screened for additional studies (Bradley et al., 2005; Bisson
et al., 2013; Imel et al., 2013; Ehring et al., 2014; Cusack et al.,
2016; Kline et al., 2018). Three independent investigators (AB,
SR and PM) carried out the search. Any discrepancies between
search results were discussed and resolved with members of the
research team (PHU and TK). As a final step, unpublished data
were identified through contacting investigators and searching
clinical trial registries (ClinicalTrials.gov and the UK Clinical
Trials Gateway).
Studies were eligible for inclusion if they were RCTs reporting
the effects of an individual or group-based psychological
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intervention for adults (mean age ⩾16 years) with PTSD (ICD-10
and/or DSM-III-IV criteria), if participants experienced at least
one of the additional CPTSD criteria at baseline (affect dysregula-
tion, negative self-concept and disturbances in relationships, as
defined in ICD-11), and if participants were free from develop-
mental or intellectual disability, neurodegenerative disorders
and acquired and/or traumatic brain injury. Studies where
participants had comorbid substance misuse difficulties or other
mental health conditions were included, but studies where parti-
cipants had a primary diagnosis of substance misuse disorder
were excluded. Case studies, uncontrolled trials and crossover
trials were not included.
To establish whether participants had clinically significant
levels of one or more of the additional CPTSD symptom clusters
at baseline, any published clinical cut-offs relating to the CPTSD
syndrome or individual CPTSD DSO symptoms were referred to
in the first instance. If these were not available, any original
validation study of the CPTSD index was referred to in order to
try to identify relevant healthy norms; if the mean of the partici-
pants was more than one standard deviation (S.D.) away from the
mean of these norms (in the direction of impairment), partici-
pants were considered to have clinically significant levels of the
relevant CPTSD index. If there was no original validation study
or if studies did not contain relevant healthy norms, studies
that contained such norms were then searched for; if there were
multiple studies, those with the largest sample sizes were priori-
tised. If the above clinical cut-offs or relevant norms could not
be obtained, a decision about clinical significance was made on
a case-by-case basis (e.g. if the participants’ mean on a CPTSD
DSO symptom indicated that they were closer to being intact
than impaired, they were not considered to have clinically signifi-
cant levels of the relevant CPTSD symptom).
We defined a ‘psychological intervention’ as a talk-based inter-
vention delivered by a trained therapist who adapted the treat-
ment to patients on the basis of a therapeutic relationship (i.e.
no delivery of a non-modifiable standard protocol, e.g. progressive
muscle relaxation) (Benish et al., 2008), and met at least two of
the following four criteria: (a) a citation to an established school
or approach to psychotherapy; (b) a description of the therapy
that contained a reference to a psychological process (e.g. operant
conditioning); (c) a reference to a treatment manual that was used
to guide the delivery of the treatment; (d) the identification of
active ingredients of the treatment and citations for these ingredi-
ents. Some of the face-to-face interventions we included did not
meet these criteria (e.g. mindfulness, yoga); however, we decided
to report their effects in the interests of completeness. Online or
other non-face-to-face interventions, even though they may meet
these criteria, were excluded because of their different method of
delivery and in an effort to reduce heterogeneity.
We further categorised psychological interventions into four
different groups: (a) CBT (see definition below); (b) exposure
therapy alone (i.e. psychological interventions, which were not
better defined as CBT, emphasizing exposure to the trauma mem-
ory as the principal active treatment component, such as PE and
imaginal exposure); (c) EMDR (i.e. psychological interventions
consistent with the manual by Shapiro, 1995); (d) other psycho-
logical interventions (e.g. mindfulness). As per NICE guidelines,
CBT was defined as a discrete psychological intervention where
service users: (i) establish links between thoughts, feelings or
actions with respect to the current or past symptoms, and/or
functioning; (ii) re-evaluate their perceptions, beliefs or reasoning
in relation to the target symptoms (National Collaborating Centre
for Mental Health, 2014). To be categorised as CBT, the interven-
tion also had to focus on at least one of the following: (iii) service
users monitoring their own thoughts, feelings or behaviours with
respect to the symptom or recurrence of symptoms; (iv) promo-
tion of alternative ways of coping with the target symptom
(National Collaborating Centre for Mental Health, 2014). Given
this broad definition of CBT, psychological interventions which
involved cognitive/imagery modification with or without expos-
ure therapy were considered to be CBT in nature.
We compared psychological intervention(s) to each other or to
a control condition, which could be treatment as usual (TAU; also
included ‘waiting list control’), or TAU plus a non-specific thera-
peutic intervention (i.e. befriending, counselling).
Outcomes and data extraction
Our primary outcome was the standardised difference between
groups at end of treatment in severity of (a) PTSD symptoms
(as per ICD-11, DSM III-IV criteria) and (b) affect dysregulation,
negative self-concept and disturbances in relationships. These
were also used to calculate the associated number needed to
treat (NNT) for clinically significant response, based on different
estimates of response rates in the control condition.
Two reviewers (PHU and AB) extracted data relating to study
characteristics, including details on participants, interventions
received and outcomes assessed. Three reviewers (PM, AB and
SR) also completed independent assessments of whether partici-
pants’ mean baseline scores on measures of CPTSD symptoms
were within the clinical range, which were then discussed and
approved by two other reviewers (TK and PHU). Study authors
were contacted in every case where CPTSD-relevant outcomes
appeared to have been assessed but not reported. To assess out-
comes, we extracted means and S.D. where possible. If S.D. were
not reported, then these were derived from standard errors (S.E.),
confidence intervals, p-values or t-values where possible, following
Cochrane Handbook procedures (Higgins and Green, 2011).
Analysis
We used Comprehensive Meta-Analysis software (version 3) for
the meta-analyses. We first calculated the post-intervention stan-
dardised mean difference (Hedges’ g) and S.E. for each individual
study on each outcome (PTSD, affect dysregulation, negative self-
concept, disturbances in relationships). Hedges’ g was selected as
the effect size measure because it accounts for variation in sample
size and sample variance (Deeks et al., 2001). A composite effect
was also computed for each study by combining PTSD and any
available CPTSD DSO outcome data. To do this, we computed
the average Hedges’ g and associated S.E. across the outcomes.
The range of measures used to assess these meant it was not feas-
ible to adjust the composite estimate for the between-outcome
correlation, we had to instead assume this was zero. When the
number of participants (N) contributing data to each domain dif-
fered, we used the smallest N for the composite estimate. When
there were sufficient data (at least two studies), we calculated
the differences between interventions and controls on PTSD,
affect dysregulation, negative self-concept and disturbances in
relationships individually, using DerSimonian and Laird (1986)
random-effects meta-analyses. We then pooled data from studies
reporting PTSD plus (a) one, two or three CPTSD DSO out-
comes, (b) two or three CPTSD DSO outcomes, and (c) all
three CPTSD DSO outcomes. The estimates were expressed in
Psychological Medicine 3
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units of Hedges’ g with associated 95% confidence intervals.
Between-group differences in clinically significant change were
derived from the Hedges’ g estimate and an assumed control
event response rate (CER) using the Furukawa method
(Furukawa, 1999; Furukawa and Leucht, 2011; http://rpsycholo-
gist.com/d3/cohend/) and presented as NNT for benefit or
harm. Morina et al. (2014) report a CER of 44% for PTSD; how-
ever, because CPTSD is assumed to have a poorer prognosis, we
estimated what the NNT to benefit or harm would be if we halved
this value to 22%. We also estimated what the NNT would be if
the natural remission rate in the control conditions was either
very high (50%) or very low (10%). Using the relative group dif-
ference and a range of assumed CERs to compute NNT is the
method recommended by the Cochrane Handbook, since this
‘helps users to understand the important impact that typical base-
line risks have on the absolute benefit that they can expect’
(Higgins and Green, 2011).
The potential impact of publication bias was assessed using
funnel plots, Egger’s test and Duval and Tweedie’s Trim-and-
Fill procedure (random-effects) (Egger et al., 1997; Duval and
Tweedie, 2000), but only for analyses derived from at least 10
studies (Higgins and Green, 2011). Cohen’s (1988) established
conventions (small = 0.2, moderate = 0.5, large = 0.8) were used
to interpret individual and meta-analytical estimates of Hedges’
g. Statistical significance was inferred when p-values were below
0.05, although values between 0.01 and 0.09 were downgraded
for imprecision. Heterogeneity was assessed using the I2 statistic,
and compared with thresholds specified in the Cochrane
Handbook (<40% low; 30–60% moderate; 50–90% substantial;
75–100% considerable) (Higgins and Green, 2011).
Assessment of study and outcome quality
Individual study quality was assessed using the Cochrane
Collaboration Risk of Bias tool (Higgins et al., 2011) and meta-
analytical estimates were assessed using the GRADE approach
(Guyatt et al., 2008) (see online Supplementary material). The
GRADE approach considers the quality of studies contributing to
each analysis, the consistency, directness and precision of the
pooled estimate, and the risk of publication bias.
Cochrane Risk of Bias ratings were completed by two reviewers
independently (PM and AB), and checked by a third (PHU). An
overall individual study quality rating was also produced (see
online Supplementary material for criteria). GRADE ratings
were performed by one reviewer (PHU) and checked by two
others (PM and TK). An overall GRADE assessment is provided
alongside each outcome to inform the interpretation of these
findings.
Moderator analyses
We combined all studies into a single dataset to conduct a series
of pre-specified univariate moderator analyses, and one multivari-
ate analysis, again using Comprehensive Meta-Analysis software
(version 3). The outcome for each meta-regression analysis was
the post-treatment group difference in CPTSD symptom severity.
For this we used, in order of preference, the composite estimates
of differences in (1) PTSD plus the three CPTSD DSO symptom
clusters; (2) PTSD plus two CPTSD DSO symptom clusters; (3)
PTSD plus one CPTSD DSO symptom cluster or (4) PTSD alone.
Pre-specified univariate analyses included the relevant
Cochrane Risk of Bias parameters (sequence generation,
allocation concealment, detection bias, reporting bias, attrition
bias), onset of trauma (childhood v. adulthood), degree to
which sample met CPTSD criteria (i.e. whether data on PTSD
plus three, two, one or no CPTSD DSO symptom clusters were
used) and therapy format (individual v. group). There were insuf-
ficient data to support pre-specified analysis of phased v. non-
phased interventions. We also examined the effect of therapy
type [individual CBT, group CBT, EMDR, exposure alone (EA),
group IPT] and the effect of using a non-specific control condi-
tion (i.e. v. a usual care/waiting list control group). To ensure
that all studies with three or more arms could be included without
double-counting of participants, we split the sample size of any
shared treatment or control arms in half for these comparisons,
as recommended in the Cochrane Handbook (Higgins and
Green, 2011), and revised the individual study effect sizes accord-
ingly. To ensure power for the multivariate analyses, we limited
this to five variables: study quality, therapy type, degree to
which sample met CPTSD criteria, trauma onset and use of a
non-specific control condition.
Results
Study selection
The search returned 28 521 results, of which 28 310 were excluded
on the basis of title or abstract (see Fig. 1). Following title and
abstract screening, the full texts of the remaining 211 articles
were examined. One hundred and forty-one full-text articles
were excluded. A further 19 full-text articles were excluded pri-
marily because they described studies that did not include clinic-
ally significant levels of one or more CPTSD DSO symptom
clusters at baseline. Fifty-one studies met full inclusion criteria
and were included in the current study. Of these, 35 studies had
a CBT arm, 11 had an exposure only arm, nine had an EMDR
arm and nine assessed the effect of other interventions, including
interpersonal psychotherapy (IPT), mindfulness, trauma manage-
ment training, dialogical exposure therapy, dialectical behaviour
therapy, CBT plus emotion regulation training and stabilisation
therapy. Figure 2 provides an overview of studies contributing
to each analysis. A table of included study characteristics and
a table of excluded studies, with reasons for exclusion, are
provided in the online Supplementary material.
Quality assessment
The results of the Cochrane Risk of Bias assessment are shown in
the online Supplementary material and GRADE ratings for each
meta-analytical outcome are shown below and in the far right col-
umn of Tables 1–4 and online Supplementary Table J.1. Just over
half of the included studies used appropriate methods to generate
a random sequence to allocate participants to groups, but poor
reporting limited our assessment of this domain. A slightly smal-
ler proportion had a low risk of bias for allocation sequence con-
cealment, but again poor reporting prevented a clear assessment
of this domain. The majority of studies had a low risk of detection
bias because assessors were unaware of the group that participants
had been allocated to. Most also had a low risk of attrition bias
with acceptable rates of missing post-intervention data (<25%).
However, most had a high risk of reporting bias primarily due
to a lack of a preregistered protocol. The risk of performance
bias was unavoidably high across all studies due to the nature
of the interventions, which precluded blinding of participants.
4 Thanos Karatzias et al.
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Overall, we rated the majority of studies as high in methodological
quality.
Meta-analytical outcomes
Cognitive behavioural therapy
As shown in Table 1, compared with usual care, CBT had a
moderate–large effect on disturbances in relationships (k = 16,
g = −0.66; 95% CI −0.84 to −0.48) and large effects on affect
dysregulation (k = 3, g =−1.42; 95% CI −2.20 to −0.65), negative
self-concept (k = 9, g =−0.82; 95% CI −1.19 to −0.44) and PTSD
symptoms (k = 27, g = −0.90; 95% CI −1.11 to −0.68) (all
moderate-quality evidence), with the NNT varying from 2 (affect
dysregulation assuming CER of 22%) to 6 (disturbances in rela-
tionships assuming CER of 10%) (Table 1 and online
Supplementary material). Moderate-to-large effects were also
observed on the composite estimates of PTSD and CPTSD DSO
symptoms (low- to high-quality evidence), with NNTs of between
3 (PTSD + 1, 2 or 3 CPTSD DSO outcomes assuming CER of
50%) and 8 (PTSD + 3 CPTSD DSO outcomes assuming CER
of 10%). However, few studies measured more than one type of
CPTSD DSO symptom. Significant publication bias was detected
whenever there were sufficient studies to assess this; however, only
the estimate for disturbances in relationships was reduced when
trim-and-fill analysis was applied. Compared with non-specific
control interventions, CBT had a small effect on disturbances in
relationships (k = 3, g = −0.32; 95% CI −0.60 to −0.03) and a
small–moderate effect on PTSD symptoms (k = 9, g = −0.37;
95% CI −0.66 to −0.09) (moderate-quality evidence), with
NNTs varying between 7 (PTSD assuming 50% CER) and 15 (dis-
turbances in relationships assuming 10% CER). Although there
was no evidence it had significant effects on affect dysregulation
and negative self-concept, few studies reported usable data.
When we pooled effects from all nine studies reporting data on
PTSD and at least one CPTSD DSO domain, a small effect was
observed (k = 9, g = −0.34; 95% CI −0.62 to −0.06; low-quality
evidence), with NNTs of between 8 (50% CER) and 14 (10%
CER), but no studies measured more than one domain.
Exposure therapy alone
As shown in Table 2, compared with usual care, exposure therapy
alone had a moderate effect on disturbances in relationships (k =
4, g = −0.59; 95% CI −1.12 to −0.07; moderate-quality evidence),
a moderate–large effect on negative self-concept (k = 3, g = −0.73;
95% CI −1.03 to −0.43; moderate-quality evidence) and a large
effect on PTSD symptoms (k = 6, g =−1.05; 95% CI −1.52 to
−0.58; low-quality evidence), with NNTs of between 3 (PTSD –
all assumed CERs) and 7 (disturbances in relationships, assuming
10% CER) (Table 2 and online Supplementary material). No stud-
ies examined whether exposure alone was superior to usual care in
relation to affect dysregulation. Moderate-to-large effects on the
composite outcomes of PTSD and CPTSD DSO symptoms were
observed (low- to high-quality evidence), with NNTs ranging
from 3 (PTSD + 1, 2 or 3 CPTSD DSO outcomes, CERs of 22%
and 50%) to 7 (PTSD + 2 or 3 CPTSD DSO outcomes, assuming
10% CER); however, only one study provided usable data on more
Fig. 1. PRISMA diagram.
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than one type of CPTSD DSO symptom. There was no evidence
that exposure alone was superior to non-specific therapies in rela-
tion to disturbances in relationships, but only one study provided
usable data. No studies reported whether exposure alone was
superior to non-specific therapies in relation to either affect dys-
regulation or negative self-concept. Two studies found no effect of
exposure alone on either PTSD data, or the composite outcome of
PTSD plus CPTSD DSO symptoms (low-quality evidence). No
studies provided data on more than one CPTSD DSO symptom.
Eye movement and desensitisation and reprocessing therapy
As shown in Table 3, compared with usual care, the few available
studies suggested EMDR had a moderate effect on negative self-
concept (k = 1, g = −0.61; 95% CI −1.04 to −0.17; low-quality evi-
dence), a moderate–large effect on disturbances in relationships
(k = 4, g =−0.76; 95% CI −1.35 to −0.16; moderate-quality evi-
dence) and large effects on affect dysregulation (k = 1, g = −1.64;
95% CI −2.56 to −0.72; very low-quality evidence) and PTSD
symptoms (k = 4, g = −1.26; 95% CI −2.01 to −0.51; low-quality
Fig. 2. Overview of studies contributing to each analysis. AD, affect dysregulation; CBT, cognitive behavioural therapy; CPTSD, complex post-traumatic stress dis-
order; DBT, dialectical behaviour therapy; DET, dialogical exposure therapy; DR, disturbances in relationships; DSO, disturbances in self-organisation; EMDR, eye-
movement and desensitisation and reprocessing therapy; ER, emotion regulation (training); IPT, interpersonal psychotherapy; NSC, negative self-concept; PTSD,
post-traumatic stress disorder; PTSD + 1, 2 or 3, PTSD + 1, 2 or 3 CPTSD (DSO) outcomes; PTSD + 2 or 3, PTSD + 2 or 3 CPTSD (DSO) outcomes; PTSD + 3, PTSD + all 3
CPTSD (DSO) outcomes; SC, supportive counselling; STBT, stabilisation treatment; TAU, treatment as usual; TMT, trauma management therapy; WL, waiting list.
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Table 1. Cognitive behavioural therapy with or without exposure v. TAU/WL or non-specific control
Outcome Comparator
k included
studies
Treatment
N
Control
N Hedges’ g (95% CI), p-value
Heterogeneity,
I2, p-value
Publication bias, p-value, adjusted g
(95% CI), k imputed studies Quality (GRADE)
DR v. TAU/WL 16 485 395 −0.66 (−0.84 to −0.48), <0.001 45%, 0.021 0.007, −0.39 (−0.59 to −0.20), 8 Moderate
-1 publication
bias
DR v. control 3 128 79 −0.32 (−0.60 to −0.03), 0.029 0%, 0.402 – Moderate
-1 imprecision
AD v. TAU/WL 3 54 61 −1.42 (−2.20 to −0.65), <0.001 71%, 0.033 – Moderate
-1 imprecision
AD v. control 2 63 62 −0.82 (−2.91 to 1.26), 0.440 94%, <0.001 – Very low
-1 inconsistency
-2 imprecision
NSC v. TAU/WL 9 320 281 −0.82 (−1.19 to −0.44), <0.001 79%, <0.001 – Moderate
-1 inconsistency
NSC v. control 4 207 163 −0.24 (−0.69 to 0.21), 0.295 75%, 0.008 – Low
-1 inconsistency
-1 imprecision
PTSD v. TAU/WL 27 899 773 −0.90 (−1.11 to −0.68), <0.001 76%, <0.001 0.002, −0.90 (−1.11 to −0.68), 0 Moderate
-1 inconsistency
PTSD v. control 9 408 323 −0.37 (−0.66 to −0.09), 0.011 71%, 0.001 – Moderate
-1 inconsistency
PTSD + 1, 2 or 3 v. TAU/WL 27 841 705 −0.81 (−1.00 to −0.62), <0.001 68%, <0.001 0.003, −0.81 (−1.00 to −0.62), 0 High
PTSD + 2 or 3 v. TAU/WL 3 92 90 −0.78 (−1.31 to −0.24), 0.005 68%, 0.043 – Moderate
-1 imprecision
PTSD + 3 v. TAU/WL 2 58 58 −0.53 (−0.96 to −0.09), 0.017 28%, 0.239 – Low
-2 imprecision
PTSD + 1, 2 or 3 v. control 9 398 314 −0.34 (−0.62 to −0.06), 0.019 68%, 0.001 – Low
-1 imprecision
-1 inconsistency
PTSD + 2 or 3 v. control 0 – – – – – –
PTSD + 3 v. control 0 – – – – – –
AD, affect dysregulation; CPTSD, complex post-traumatic stress disorder; DR, disturbances in relationships; DSO, disturbances in self-organisation; NSC, negative self-concept; PTSD, post-traumatic stress disorder; PTSD + 1, 2 or 3, PTSD + 1, 2 or 3 CPTSD
(DSO) outcomes; PTSD + 2 or 3, PTSD + 2 or 3 CPTSD (DSO) outcomes; PTSD + 3, PTSD + all 3 CPTSD (DSO) outcomes; TAU, treatment as usual; WL, waiting list.
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Table 2. Exposure only v. TAU/WL or non-specific control
Outcome Comparator
k included
studies
Treatment
N
Control
N Hedges’ g (95% CI), p-value
Heterogeneity, I2,
p-value
Publication bias, p-value,
adjusted g (95% CI), k imputed
studies
Quality
(GRADE)
DR v. TAU/WL 4 158 110 −0.59 (−1.12 to −0.07), 0.028 73%, 0.011 – Moderate
-1 imprecision
DR v. control 1 47 24 −0.12 (−0.60 to 0.37), 0.642 – – Very low
-2 RoB
-2 imprecision
AD v. TAU/WL 0 – – – – – –
AD v. control 0 – – – – – –
NSC v. TAU/WL 3 131 102 −0.73 (−1.03 to −0.43), <0.001 21%, 0.283 – Moderate
-1 imprecision
NSC v. control 0 – – – – – –
PTSD v. TAU/WL 6 246 190 −1.05 (−1.52 to −0.58), <0.001 79%, <0.001 – Low
-2 imprecision
PTSD v. control 2 67 42 −0.08 (−0.47 to 0.30), 0.675 0%, 0.803 – Low
-2 imprecision
PTSD + 1, 2 or 3 v. TAU/WL 6 242 158 −0.86 (−1.25 to −0.47), <0.001 69%, 0.006 – High
PTSD + 2 or 3 v. TAU/WL 1 47 39 −0.56 (−0.99 to −0.14), 0.009 – – Low
-2 imprecision
PTSD + 3 v. TAU/WL 0 – – – – – –
PTSD + 1, 2 or 3 v. control 2 67 42 −0.19 (−0.57 to 0.20), 0.336 0%, 0.636 – Low
-2 imprecision
PTSD + 2 or 3 v. control 0 – – – – – –
PTSD + 3 v. control 0 – – – – – –
AD, affect dysregulation; CPTSD, complex post-traumatic stress disorder; DSO, disturbances in self-organisation; DR, disturbances in relationships; NSC, negative self-concept; PTSD, post-traumatic stress disorder; PTSD + 1, 2 or 3, PTSD + 1, 2 or 3 CPTSD
(DSO) outcomes; PTSD + 2 or 3, PTSD + 2 or 3 CPTSD (DSO) outcomes; PTSD + 3, PTSD + all 3 CPTSD (DSO) outcomes; RoB, risk of bias; TAU, treatment as usual; WL = waiting list.
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Table 3. EMDR v. TAU/WL or non-specific control
Outcome Comparator
k included
studies
Treatment
N
Control
N Hedges’ g (95% CI), p-value
Heterogeneity, I2,
p-value
Publication bias, p-value,
adjusted g (95% CI), k imputed
studies Quality (GRADE)
DR v. TAU/WL 4 94 84 −0.76 (−1.35 to −0.16), 0.012 70%, 0.019 – Moderate
-1 imprecision
DR v. control 2 37 34 −0.35 (−1.01 to 0.31), 0.312 46%, 0.174 – Very low
-2 RoB
-2 imprecision
-1 inconsistency
AD v. TAU/WL 1 11 12 −1.64 (−2.56 to −0.72), <0.001 – – Very low
-2 RoB
-2 imprecision
AD v. control 1 11 10 0.25 (−0.57 to 1.08), 0.548 – – Very low
-2 RoB
-2 imprecision
NSC v. TAU/WL 1 44 39 −0.61 (−1.04 to −0.17), 0.006 – – Low
-2 imprecision
NSC v. control 2 56 53 −0.78 (−1.56 to −0.01), 0.049 75%, 0.047 – Very low
-1 inconsistency
-2 imprecision
PTSD v. TAU/WL 4 105 92 −1.26 (−2.01 to −0.51), 0.001 79%, 0.002 – Low
-1 inconsistency
-1 imprecision
PTSD v. control 3 70 65 −0.69 (−1.35 to −0.03), 0.041 70%, 0.035 – Very low
-1 RoB
-1 inconsistency
-1 imprecision
PTSD + 1, 2 or 3 v. TAU/WL 4 94 84 −1.15 (−1.92 to −0.37), 0.004 81%, 0.002 – Low
-1 inconsistency
-1 imprecision
PTSD + 2 or 3 v. TAU/WL 2 55 51 −1.36 (−3.13 to 0.42), 0.134 90%, 0.001 – Very low
-1 inconsistency
-2 imprecision
PTSD + 3 v. TAU/WL 0 – – – – – –
PTSD + 1, 2 or 3 v. control 3 67 61 −0.52 (−0.97 to −0.08), 0.020 35%, 0.213 – Low
-1 RoB
-1 imprecision
PTSD + 2 or 3 v. control 2 37 34 −0.44 (−1.31 to 0.43), 0.321 68%, 0.079 – Very low
-2 RoB
-1 inconsistency
-2 imprecision
PTSD + 3 v. control 0 – – – – – –
AD, affect dysregulation; CPTSD, complex post-traumatic stress disorder; DR, disturbances in relationships; DSO, disturbances in self-organisation; EMDR, eye-movement and desensitisation and reprocessing therapy; NSC, negative self-concept; PTSD,
post-traumatic stress disorder; PTSD + 1, 2 or 3, PTSD + 1, 2 or 3 CPTSD (DSO) outcomes; PTSD + 2 or 3, PTSD + 2 or 3 CPTSD (DSO) outcomes; PTSD + 3, PTSD + all 3 CPTSD (DSO) outcomes; RoB, risk of bias; TAU, treatment as usual; WL, waiting list.
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evidence), with NNTs ranging from 2 (affect dysregulation, all
CERs) to 7 (disturbances in relationships, assuming CER of
10%) (Table 3 and online Supplementary material). EMDR also
had a large effect on the composite outcome of PTSD and at
least one CPTSD DSO symptom (k = 4, g =−1.15; 95%
CI −1.92 to −0.37; low-quality evidence), with NNTs of 2 (CER
of 22%) or 3 (CER of 10% or 50%), but it did not have an effect
on the composite outcome of PTSD and more than one CPTSD
DSO symptom (very low-quality evidence). There was no evi-
dence that EMDR was superior to non-specific interventions in
relation to disturbances in relationships or affect dysregulation
(very low-quality evidence). Although moderate–large effects on
negative self-concept (k = 2, g =−0.78; 95% CI −1.56 to −0.01)
and PTSD symptoms (k = 3, g = −0.69; 95% CI −1.35 to −0.03)
(very low-quality evidence) were observed, with NNTs of between
4 (negative self-concept, all CERs) and 6 (PTSD; CER of 10%),
these analyses were based on only 2–3 studies. A moderate effect
on the composite outcome of PTSD and at least one CPTSD DSO
symptom was observed (k = 3, g =−0.52; 95% CI −0.97 to −0.08;
low-quality evidence), with NNTs of between 5 (CER 50%) and 8
(CER 10%), but no effect was found on the composite outcome of
PTSD and more than one CPTSD DSO symptom (very low-
quality evidence).
Comparison of CBT, exposure and EMDR
As shown in Table 4, there was very limited evidence that EMDR
had a small–moderate advantage over CBT in relation to PTSD
symptoms (k = 2, g = 0.37; 95% CI 0.03–0.71; low-quality evi-
dence), with an NNT of 7–12, but no differences between CBT,
exposure alone and EMDR were observed for any other outcomes
(Table 4 and online Supplementary material).
Other comparisons
As shown in online Supplementary Table J.1, one small study
(Krupnick et al., 2008) found IPT had an advantage over usual
care in reducing PTSD plus disturbances in relationships (k = 1,
g = −1.02; 95% CI −1.65 to −0.39; very low-quality evidence),
with an NNT of 3–4, and another small study (Azad Marzabadi
and Hashemi Zadeh, 2014) found mindfulness was more effective
than usual care in relation to disturbances in relationships (k = 1,
g = −1.60; 95% CI −2.43 to −0.77; very low-quality evidence),
with an NNT of 2–3. Several other small studies compared vari-
ous psychotherapeutic interventions to other interventions, or
to CBT, exposure or EMDR. We found no evidence to favour
any particular intervention in relation to the composite outcome
of PTSD plus CPTSD DSO symptoms (very low- to low-quality
evidence).
Moderator analyses
As shown in online Supplementary Table L.1, use of a non-
specific control condition rather than usual care or waiting list
was associated with a smaller benefit of psychological therapy
in univariate meta-regression, with a reduction in Hedges’ g of
0.48 (95% CI 0.18–0.77). No other moderators were significant
when examined individually. As shown in online
Supplementary Table M.1, the effect of using a non-specific con-
trol condition was larger in multivariate meta-regression, with a
reduction in Hedges’ g of 0.69 (95% CI 0.39–1.00) in this analysis.
Study quality and age of trauma onset also emerged as significant
moderators of therapy effects in this analysis. Low-quality studies
were associated with a significantly lower effect size, with a reduc-
tion in Hedges’ g of 0.30 (95% CI 0.00–0.61). Studies where
participants had predominantly childhood-onset trauma were
associated with a reduction in Hedges’ g of 0.35 (95% CI 0.02–
0.69), when compared with trials where most participants had
adult-onset trauma (Fig. 3).
Discussion
We examined evidence from RCTs of psychological treatments
for PTSD where participants were also likely to have clinically sig-
nificant levels of one or more CPTSD DSO symptoms at baseline,
and where usable data on the effect of interventions on these
symptoms were reported. A total of 51 studies met inclusion cri-
teria. Overall, results indicate that when compared with usual
care, CBT, exposure alone and EMDR perform relatively equally
for symptoms of PTSD and the DSO symptoms of negative self-
concept and disturbances in relationships. While the quality of
this evidence was moderate for CBT, it ranged from low to mod-
erate for exposure alone and EMDR. Few trials reported the
effectiveness of psychological therapies for symptoms of affect
dysregulation. Low-quality evidence suggests that EMDR has a
small–moderate advantage over CBT in relation to PTSD symp-
toms, but there was no evidence of any differences between
CBT, exposure alone or EMDR for the other outcomes including
DSO symptoms. Univariate and multivariate meta-regression
confirmed that the effectiveness of psychological therapies was
considerably lower when compared with non-specific therapies,
which suggests that non-specific effects may account for a large
proportion of therapeutic change in symptoms of CPTSD in
these trials. The multivariate meta-regression also found that
treatment outcome may be moderated by the developmental
time of the onset of psychological trauma, with childhood trauma
being associated with smaller effects of psychological therapies on
CPTSD symptoms.
The data are encouraging in that the accumulation of evidence
suggests that there are specific interventions that work for several
of the CPTSD symptom clusters. The data also suggest that no
particular type of intervention (exposure, cognitive re-appraisal,
bilateral stimulation) is necessary to resolve any one symptom
cluster. A critical question is whether current treatments devised
for PTSD are equally effective for those who will be diagnosed
with CPTSD. Our results replicate earlier findings that individual
trauma-focused treatments show large effect sizes. Although
the evidence is at a very early stage, we found that some non-
trauma-focused therapies, such as mindfulness and IPT, may
also reduce PTSD and/or disturbances in relationships, suggesting
alternative options. Importantly, childhood abuse was found to
moderate all outcomes across all types of treatments, suggesting
those with a history of childhood trauma may experience less
improvement, and that current treatments for this patient popu-
lation can be improved. These results have implications for the
treatment of CPTSD as those with childhood abuse are at risk
for CPTSD and in this meta-analysis may represent those more
likely to have the full symptom profile.
Research is needed to determine how to optimise treatment
outcomes for those with childhood abuse and other populations
at risk for CPTSD. This includes identifying which treatment
interventions are most effective for specific symptom clusters,
which are most acceptable to patients, in what order to present
interventions and the optimal duration of different types of inter-
ventions. Considering current debates in the literature, it would
have been useful to explore the usefulness of phased v. non-
phased interventions and individual v. group interventions for
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Table 4. Comparison of CBT, exposure and EMDR
Outcome Comparison (A v. B)
k included
studies Group A N Group B N Hedges’ g (95% CI), p-value
Heterogeneity, I2,
p-value
Publication bias, p-value, adjusted
g (95% CI), k imputed studies
Quality
(GRADE)
DR CBT v. exposure
alone
3 152 120 0.07 (−0.26 to 0.39), 0.689 38%, 0.200 – Moderate
-1 imprecision
AD CBT v. exposure
alone
0 – – – – – –
NSC CBT v. exposure
alone
1 62 61 −0.31 (−0.67 to 0.04), 0.082 – – Very low
-2 RoB
-2 imprecision
PTSD CBT v. exposure
alone
4 216 184 −0.03 (−0.23 to 0.17), 0.784 0%, 0.493 – Moderate
-1 imprecision
PTSD + 1, 2 or 3 CBT v. exposure
alone
4 214 181 −0.04 (−0.27 to 0.19), 0.719 20%, 0.291 – Moderate
-1 imprecision
PTSD + 2 or 3 CBT v. exposure
alone
0 – – – – – –
PTSD + 3 CBT v. exposure
alone
0 – – – – – –
DR CBT v. EMDR 2 59 70 0.28 (−0.29 to 0.34), 0.338 60%, 0.115 − Very low
-2 imprecision
-1
inconsistency
AD CBT v. EMDR 0 – – – – – –
NSC CBT v. EMDR 0 – – – – – –
PTSD CBT v. EMDR 2 62 75 0.37 (0.03 to 0.71), 0.031 0%, 0.548 – Low
-2 imprecision
PTSD + 1, 2 or 3 CBT v. EMDR 2 59 70 0.31 (−0.07 to 0.68), 0.111 16%, 0.275 – Low
-2 imprecision
PTSD + 2 or 3 CBT v. EMDR 0 – – – – – –
PTSD + 3 CBT v. EMDR 0 – – – – – –
DR EMDR v. exposure
alone
1 44 47 −0.10 (−0.51 to 0.31), 0.640 − − Low
-2 imprecision
AD EMDR v. exposure
alone
0 – – – – – –
NSC EMDR v. exposure
alone
1 44 47 0.16 (−0.25 to 0.57), 0.444 – – Low
-2 imprecision
PTSD EMDR v. exposure
alone
1 55 48 0.10 (−0.28 to 0.49), 0.604 – – Low
-2 imprecision
PTSD + 1, 2 or 3 EMDR v. exposure
alone
1 44 47 0.06 (−0.35 to 0.46), 0.789 – – Low
-2 imprecision
(Continued )
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CPTSD. Unfortunately, we did not find adequate evidence to
enable further analysis of these treatment outcome moderators.
There is substantial evidence indicating that CPTSD and PTSD
represent distinct patient populations with different symptom
profiles (Brewin et al., 2017), suggesting the value of developing
treatments that more precisely and effectively resolve the differing
effects of trauma exposure by systematically testing type, order
and duration of interventions specific to each disorder and taking
into account patient preferences across both disorders (Cloitre,
2015).
Our meta-analysis has a number of strengths. We minimised
the risk of bias by pre-registering the review, and we minimised
errors and omissions by having two or more reviewers conduct
comprehensive searches, assess study quality and extract descrip-
tive data. We considered a range of treatments from different
countries and included participants with a range of backgrounds
and types of psychological trauma including military, civilian and
childhood trauma. Many studies have used qualified therapists
and considered assessments of adherence to the protocol.
However, most of the research was conducted in western coun-
tries, thus limiting the extent to which the findings may generalise
to non-western countries. Furthermore, the evidence we have
reviewed as part of this meta-analysis was predominantly on
DSM-IV PTSD. Most studies did not present data on multiple
traumatisation which typically results in CPTSD (Karatzias
et al., 2016). Even when the index trauma that was targeted
occurred in adulthood in included studies, it would be useful to
assess lifetime traumatic history and consider the accumulative
effect of multiple traumatisation. In relation to outcomes, we
have only considered therapeutic gains at post-treatment. Future
research should explore long-term outcomes of these interven-
tions. Furthermore, for this meta-analysis we have used proxy
measures for the CPTSD constructs. It might well be the case
that a number of studies that included people with CPTSD have
not been included in the study as they have not reported out-
comes on relevant constructs or reported outcomes have not
met clinical thresholds or our definition of ‘clinical significance’.
It might also be the case that the measures employed in included
studies do not accurately reflect the corresponding DSO clusters,
thus introducing some measurement bias. Moreover, while the
quality of the meta-analytical evidence was high or moderate
for some of the outcomes (e.g. when CBT was compared with
usual care or non-specific control interventions), it was low or
very low for most of the outcomes. Related to this, there was sub-
stantial heterogeneity for just over half of the outcomes. Thus,
there is some uncertainty in the conclusions that can be drawn.
It is also worth noting that we did not downgrade the
meta-analytical outcomes for indirectness, as indirect evidence
of psychological interventions for CPTSD was the focus of this
review. If, on the other hand, we had been interested in direct evi-
dence of psychological interventions for CPTSD, most if not all
the outcomes would have been downgraded for indirectness.
There is clearly a need for further well-designed trials of
psychological therapies that incorporate appropriate methods of
randomisation, blinding of assessors, long-term follow-up and
appropriate training of therapists and monitoring of treatment
adherence. We have identified a set of research priorities to bene-
fit people with CPTSD in the future that might directly or indir-
ectly result from the findings of this review:
• Effectiveness of phased v. non-phased interventions for CPTSD:
very few included studies in this meta-analysis haveTa
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incorporated a phased approach to treatment and it was not
possible to address this question.
• Effectiveness of trauma-focused treatments v. non-trauma-
focused treatments. Existing evidence is predominantly focused
on trauma-focused treatments.
• Head-to-head comparisons between trauma-focused treatments
for CPTSD. Most studies explored the effectiveness of interven-
tions against standard care or no treatment.
• Exploring safety of trauma-focused therapies for CPTSD. It is
essential that future research in this area provides information
on adverse effects.
• Investigation of whether diagnosis of CPTSD moderates out-
comes when compared against those who do not meet diagnosis
in standard treatments. Clinical reality suggests that many peo-
ple do not meet full diagnostic criteria but still suffer from a
number of debilitating symptoms that relate to that condition.
• Appropriateness and effectiveness of trauma-focused treat-
ments for CPTSD following childhood trauma. In this meta-
analysis, childhood trauma was found to negatively moderate
the effect of trauma-focused interventions.
• Comparing pharmacotherapy v. psychotherapy for CPTSD. In
this meta-analysis, we did not address the effectiveness of phar-
macotherapies alone or in combination with psychotherapy.
• Considering the nature of the three DSO factors, it is worth
exploring the effectiveness of attachment-based interventions
and relational therapies as limited evidence is currently present
for these interventions.
• Exploring the effectiveness of individual v. group interventions
for CPTSD. We found no evidence addressing this question for
people with CPTSD.
• Exploring the effectiveness of interventions that tackle all
CPTSD symptom clusters in a single study using as a primary
outcome of CPTSD based on a dedicated measure. The present
review extracted proxy data from existing trials that measure the
CPTSD constructs.
In conclusion, this meta-analysis is the first step in identifying
effective treatments for CPTSD. Findings regarding the usefulness
of trauma-focused interventions look promising but less so for
CPTSD symptoms following childhood trauma. Further research
is needed to explore and develop existing and new treatments for
CPTSD.
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